NCT03670095View on ClinicalTrials.gov

Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 28, 2018

Primary Completion Date

December 24, 2018

Study Completion Date

December 24, 2018

Conditions

Healthy

Interventions

DRUG

Lactose-free memantine

Lactose-free memantine tablet, 10 mg; orally as a single dose

DRUG

Memantine

Lactose-containing memantine tablet, 10 mg, orally as a single dose

Trial Locations (1)

Unknown

Shuguang Hospital, Shanghai TCM University, Shanghai

All Listed Sponsors

lead

H. Lundbeck A/S

INDUSTRY

NCT03670095 - Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed Conditions | Biotech Hunter | Biotech Hunter